BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2979675)

  • 1. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
    Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
    Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour intragastric measurements in twenty healthy subjects: effect of enisoprost, a novel and potent antisecretory and antipeptic synthetic E1 prostaglandin.
    Thomson AB; McCullough HN; Kirdeikis P; Zuk L; Simpson I; Cook DJ; Wildeman RA; Brunet K; Fisher D; Pinchbeck B
    Aliment Pharmacol Ther; 1988 Aug; 2(4):325-36. PubMed ID: 2979255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective on the gastric antisecretory effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of misoprostol on gastric acid and mucus secretion in man.
    Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.
    Davis GR; Fordtran JS; Dajani EZ
    Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pepsin release by prostaglandin E1 analogue. A potential therapeutic problem.
    Basson MD; Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Arch Surg; 1988 Apr; 123(4):431-3. PubMed ID: 3126724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.
    Tsai BS; Kessler LK; Butchko GM; Bauer RF
    Dig Dis Sci; 1987 Sep; 32(9):1010-6. PubMed ID: 3040357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha chain unsaturated derivatives of misoprostol.
    Collins PW; Gasiecki AF; Weier RM; Kramer SW; Jones PH; Gullikson GW; Bianchi RG; Bauer RF
    Prostaglandins; 1987; 33 Suppl():17-28. PubMed ID: 3122273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18-cycloalkyl analogues of enisoprost.
    Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Jones PH; Bauer RF
    J Med Chem; 1989 May; 32(5):1001-6. PubMed ID: 2709370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins.
    Bertaccini G; Adami M; Coruzzi G
    Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
    Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
    Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of nizatidine and misoprostol on peptic activity and gastric mucus].
    Grassi SA; Vianello F; Germanà B; Dal Santo P; Faggian D; Battaglia G; Plebani M; Di Mario F; Naccarato R
    Medicina (Firenze); 1990; 10(1):29-31. PubMed ID: 1974318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the synthetic PGE1 derivative misoprostol on basal, stimulated and nocturnal acid secretion in duodenal ulcer cases. Mechanism of action.
    Buzás G; Puscas I; Persa F; Reznicek A
    Acta Physiol Hung; 1989; 73(2-3):185-91. PubMed ID: 2512765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
    Silverstein FE; Kimmey MB; Saunders DR; Levine DS
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of misoprostol on gastric pepsin secretion and human mucosal cell loss in man.
    Quadros E; Wilson DE
    J Assoc Acad Minor Phys; 1990; 1(2):17-9. PubMed ID: 2135692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of misoprostol on histamine-related gastric secretion in man.
    Wilson DE; Wilson PC
    J Assoc Acad Minor Phys; 1989; 1(1):16-8. PubMed ID: 2520847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociated effects of misoprostol on gastric acid secretion and mucosal blood flow.
    Leung FW; Miller JC; Guth PH
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):86S-90S. PubMed ID: 3080295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol clinical pharmacology. Establishment of activity in man.
    Steiner JA
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):136S-141S. PubMed ID: 3932046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.